Le Lézard
Classified in: Health, Business
Subject: CON

Think Research Announces Change of Auditor to Ernst & Young LLP


TORONTO, Sept. 24, 2021 /CNW/ - Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, today announced that it has changed its auditor from MNP LLP (the "Former Auditor") to Ernst & Young LLP (the "Successor Auditor") effective September 14, 2021 (the "Effective Date").

At the request of the Company, the Former Auditor resigned as auditor of the Company and the board of directors of the Company appointed the Successor Auditor as the Company's auditor to hold office until the next annual meeting of the shareholders of the Company, each effective as of the Effective Date.

Think Chief Financial Officer Jae Cornelssen said "Due to our rapid growth and expansion, the Company has transitioned to a bigger and more international accounting firm in Ernst & Young LLP. We would like to thank MNP LLP for their services and contributions to Think."

There were no modified opinions in the Former Auditor's reports in connection with the audits of the Company's fiscal period ended December 31, 2020 and the fiscal year ended September 30, 2020. There have been no further audits of financial statements subsequent to the Company's fiscal period ended December 31, 2020 and ending on or prior to the Effective Date. There have been no reportable events, as such term is defined in National Instrument 51-102 - Continuous Disclosure Obligations ("NI 51-102"), between the Company and the Former Auditor.

In accordance with NI 51-102, the Notice of Change of Auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the Audit Committee and the Board of Directors of the Company and will be filed on the Company's SEDAR profile at www.sedar.com.

About Think Research Corporation

Think Research Corporation is an industry leader in delivering knowledge-based digital health software solutions. The Company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes. For over a decade, Think's cloud-based, EMR-agnostic digital tools have empowered clinicians around the world and positively impacted millions of patients across the continuum of care ? including primary physician care, acute care hospitals and surgical suites as well as community and seniors care. Think is proud to serve as a trusted health system partner to a rapidly growing, global client base that spans five continents and more than 2,800 healthcare facilities.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information: https://www.thinkresearch.com/ca/investors/.

SOURCE Think Research Corporation


These press releases may also interest you

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining...

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals...

at 22:10
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lincoln National Corporation ("Lincoln National" or "the Company") and certain of its...

at 21:29
TSX VENTURE COMPANIES BULLETIN V2024-1211 ALPHAMIN RESOURCES CORP.  ("AFM")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  April 26, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend Amount per Common...

at 21:22
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year  ended January 31, 2024.  The Company recorded net earnings and comprehensive income attributable to shareholders of the...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: